Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Christopher Lieu

Concepts (416)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
53
2026
870
9.630
Why?
Antineoplastic Combined Chemotherapy Protocols
25
2026
1996
2.690
Why?
Colonic Neoplasms
9
2026
257
2.670
Why?
Biomarkers, Tumor
23
2026
1334
2.360
Why?
Molecular Targeted Therapy
9
2019
446
1.850
Why?
Antineoplastic Agents
14
2021
2218
1.790
Why?
Antibodies, Monoclonal, Humanized
12
2026
992
1.680
Why?
Rectal Neoplasms
7
2023
159
1.590
Why?
Bevacizumab
5
2024
167
1.540
Why?
Immunotherapy
5
2026
669
1.480
Why?
Benzimidazoles
3
2024
189
1.450
Why?
Neoplasms
14
2025
2944
1.370
Why?
Drug Resistance, Neoplasm
10
2026
889
1.100
Why?
Microsatellite Instability
11
2026
57
1.100
Why?
Pancreatic Neoplasms
11
2025
944
1.040
Why?
Mutation
15
2025
4082
1.010
Why?
Circulating Tumor DNA
5
2026
50
0.990
Why?
Neoplasm Staging
14
2026
1486
0.970
Why?
Age of Onset
9
2024
557
0.950
Why?
Gastrointestinal Neoplasms
2
2025
74
0.930
Why?
Tankyrases
1
2025
13
0.910
Why?
Cetuximab
5
2025
110
0.820
Why?
Vascular Endothelial Growth Factor A
4
2020
543
0.820
Why?
Neuroendocrine Tumors
6
2024
122
0.810
Why?
Fluorouracil
8
2026
231
0.770
Why?
Proto-Oncogene Proteins p21(ras)
4
2019
250
0.770
Why?
Humans
109
2026
145625
0.760
Why?
Oncologists
1
2023
47
0.750
Why?
Proto-Oncogene Proteins B-raf
6
2024
230
0.730
Why?
Indoles
1
2025
509
0.680
Why?
Antibodies, Monoclonal
6
2023
1511
0.660
Why?
Leucovorin
7
2026
98
0.640
Why?
Middle Aged
45
2026
36359
0.630
Why?
Carcinoma, Pancreatic Ductal
4
2025
297
0.630
Why?
Wnt Signaling Pathway
3
2025
211
0.630
Why?
Pyrimidinones
2
2024
124
0.620
Why?
Colectomy
2
2026
107
0.600
Why?
Aged
36
2026
26251
0.600
Why?
DNA Mismatch Repair
5
2026
54
0.600
Why?
Camptothecin
5
2025
139
0.590
Why?
Pyridones
2
2024
210
0.580
Why?
Neoplasm Metastasis
9
2025
693
0.570
Why?
Early Detection of Cancer
4
2025
501
0.560
Why?
Piperidines
2
2017
223
0.550
Why?
Disease-Free Survival
8
2026
777
0.550
Why?
Adult
40
2026
40821
0.540
Why?
Neoadjuvant Therapy
6
2026
474
0.520
Why?
Azetidines
1
2017
45
0.510
Why?
Cyclosporine
1
2018
256
0.510
Why?
Genetic Predisposition to Disease
4
2022
2455
0.490
Why?
Appendiceal Neoplasms
2
2020
28
0.490
Why?
Terminology as Topic
1
2019
253
0.490
Why?
Chemotherapy, Adjuvant
6
2026
429
0.480
Why?
Male
47
2026
73014
0.470
Why?
Precision Medicine
2
2026
462
0.460
Why?
Neoplasms, Unknown Primary
2
2026
20
0.450
Why?
Female
48
2026
79080
0.450
Why?
MAP Kinase Kinase Kinases
1
2015
70
0.440
Why?
Adrenal Gland Neoplasms
3
2022
99
0.440
Why?
Patient Rights
1
2015
11
0.440
Why?
Kaplan-Meier Estimate
7
2025
959
0.440
Why?
Treatment Outcome
16
2026
11744
0.440
Why?
Therapies, Investigational
1
2015
18
0.440
Why?
Medical Oncology
5
2023
344
0.430
Why?
Drug and Narcotic Control
1
2015
24
0.430
Why?
Drugs, Investigational
1
2015
31
0.430
Why?
Neovascularization, Pathologic
2
2013
285
0.420
Why?
Healthcare Disparities
1
2021
728
0.410
Why?
Relaxation Therapy
1
2014
19
0.400
Why?
Leisure Activities
1
2014
31
0.400
Why?
Adenocarcinoma
5
2023
927
0.390
Why?
Stroke Rehabilitation
1
2014
44
0.390
Why?
Pyrazines
2
2018
94
0.390
Why?
Immunoglobulin G
1
2017
899
0.370
Why?
Drug Evaluation, Preclinical
1
2013
195
0.370
Why?
Microsatellite Repeats
2
2024
159
0.370
Why?
Clinical Trials as Topic
4
2025
1062
0.370
Why?
Drug Design
1
2013
179
0.360
Why?
ErbB Receptors
5
2017
636
0.360
Why?
Xenograft Model Antitumor Assays
7
2025
928
0.340
Why?
Cell Transformation, Neoplastic
1
2013
314
0.340
Why?
Carcinoma, Signet Ring Cell
1
2011
17
0.330
Why?
Terminal Care
1
2015
284
0.330
Why?
Carcinoma, Squamous Cell
2
2026
627
0.320
Why?
Imidazoles
2
2024
244
0.310
Why?
Fibroblast Growth Factors
1
2011
187
0.310
Why?
Dose-Response Relationship, Drug
3
2025
2018
0.310
Why?
Organoplatinum Compounds
3
2026
65
0.310
Why?
src-Family Kinases
1
2010
93
0.300
Why?
Clinical Decision-Making
4
2024
364
0.290
Why?
Genomics
4
2025
851
0.290
Why?
Maximum Tolerated Dose
2
2025
216
0.290
Why?
Patient Selection
3
2019
720
0.280
Why?
Disease Management
4
2021
649
0.270
Why?
Boronic Acids
1
2008
37
0.270
Why?
Aged, 80 and over
14
2026
8351
0.270
Why?
Janus Kinase 2
1
2008
31
0.270
Why?
Myeloproliferative Disorders
1
2008
21
0.270
Why?
Etoposide
1
2008
169
0.270
Why?
Stomach Neoplasms
3
2022
128
0.270
Why?
Carboplatin
1
2008
168
0.260
Why?
Patient-Centered Care
2
2025
551
0.250
Why?
Carcinoembryonic Antigen
2
2024
40
0.250
Why?
Pathology, Molecular
2
2017
28
0.250
Why?
Pathology, Clinical
2
2017
29
0.250
Why?
Shock, Septic
1
2009
230
0.240
Why?
Cancer Survivors
2
2024
347
0.240
Why?
Drug Administration Schedule
4
2019
782
0.240
Why?
Health Services Accessibility
1
2015
1101
0.240
Why?
Organ Sparing Treatments
1
2026
37
0.230
Why?
B7-H1 Antigen
3
2026
245
0.230
Why?
ras Proteins
2
2017
148
0.230
Why?
Oncology Service, Hospital
1
2025
15
0.230
Why?
Anus Neoplasms
1
2026
33
0.230
Why?
Ipilimumab
1
2026
44
0.230
Why?
CD47 Antigen
1
2025
41
0.230
Why?
Age Factors
5
2021
3321
0.220
Why?
Diagnosis, Differential
1
2009
1500
0.210
Why?
United States
14
2025
16041
0.210
Why?
Oximes
1
2024
26
0.210
Why?
Fluorescence Resonance Energy Transfer
1
2025
180
0.210
Why?
Young Adult
6
2026
14240
0.210
Why?
Benchmarking
1
2025
192
0.200
Why?
Cell Line, Tumor
6
2025
3538
0.200
Why?
Prognosis
10
2026
4331
0.200
Why?
CD3 Complex
1
2024
112
0.200
Why?
Deoxycytidine
3
2024
219
0.200
Why?
Metastasectomy
1
2023
19
0.190
Why?
Antibodies, Bispecific
1
2024
70
0.190
Why?
Trifluridine
1
2022
3
0.190
Why?
Clinical Trials, Phase II as Topic
2
2022
74
0.190
Why?
Extracellular Vesicles
1
2025
175
0.190
Why?
Signal Transduction
6
2018
5234
0.190
Why?
Retrospective Studies
11
2026
17291
0.190
Why?
Neoplasm Grading
2
2024
313
0.180
Why?
Surgical Oncology
1
2022
30
0.180
Why?
Empathy
1
2024
184
0.180
Why?
Clinical Trials, Phase III as Topic
2
2022
116
0.180
Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2023
167
0.180
Why?
Academic Medical Centers
1
2025
560
0.180
Why?
Databases, Factual
4
2017
1481
0.180
Why?
Ovarian Neoplasms
2
2020
598
0.180
Why?
Genetic Testing
3
2022
491
0.180
Why?
Membrane Proteins
3
2019
1130
0.180
Why?
Disease Models, Animal
4
2021
4565
0.170
Why?
Chemoradiotherapy, Adjuvant
2
2023
44
0.170
Why?
Survival Rate
6
2023
2078
0.170
Why?
Incidence
6
2022
2910
0.170
Why?
Neoplasms, Multiple Primary
1
2022
57
0.170
Why?
Gene Regulatory Networks
1
2024
319
0.170
Why?
Tumor Microenvironment
2
2023
745
0.170
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2022
42
0.170
Why?
DNA
1
2008
1418
0.170
Why?
Pheochromocytoma
1
2022
67
0.160
Why?
Meningioma
1
2022
87
0.160
Why?
Capecitabine
2
2022
56
0.160
Why?
Heterografts
1
2021
143
0.160
Why?
Congresses as Topic
2
2019
226
0.160
Why?
Health Status Disparities
2
2020
321
0.160
Why?
Practice Patterns, Physicians'
1
2009
1370
0.150
Why?
Immune System
1
2021
181
0.150
Why?
Artificial Intelligence
1
2024
385
0.150
Why?
Adenomatous Polyposis Coli Protein
1
2019
20
0.150
Why?
Smad4 Protein
1
2019
33
0.150
Why?
Area Under Curve
2
2018
333
0.150
Why?
Retinal Vein
1
2019
14
0.140
Why?
GTP Phosphohydrolases
1
2019
95
0.140
Why?
Tumor Suppressor Protein p53
2
2022
530
0.140
Why?
Prevalence
2
2026
2852
0.140
Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
109
0.140
Why?
Animals
12
2025
38030
0.140
Why?
Cell-Free Nucleic Acids
1
2019
39
0.140
Why?
Genes, ras
1
2018
70
0.140
Why?
Vasculitis
1
2019
69
0.140
Why?
Disease Progression
4
2017
2857
0.140
Why?
Neoplasm Transplantation
1
2018
238
0.130
Why?
Evidence-Based Medicine
2
2019
727
0.130
Why?
Retinal Diseases
1
2019
101
0.130
Why?
Proportional Hazards Models
3
2017
1318
0.130
Why?
Drug Combinations
2
2022
399
0.130
Why?
Survivorship
1
2018
59
0.130
Why?
Patient Advocacy
1
2018
73
0.130
Why?
Acneiform Eruptions
1
2017
1
0.130
Why?
Population Surveillance
1
2021
477
0.130
Why?
Asthenia
1
2017
3
0.130
Why?
Cohort Studies
6
2020
6045
0.130
Why?
Risk Factors
6
2022
10840
0.130
Why?
Risk Assessment
2
2019
3678
0.130
Why?
Drug Eruptions
1
2017
28
0.130
Why?
Hypokalemia
1
2017
23
0.130
Why?
Histone Deacetylase Inhibitors
1
2019
218
0.130
Why?
MAP Kinase Kinase 1
1
2017
70
0.130
Why?
Receptor, ErbB-3
1
2017
48
0.130
Why?
Patient Compliance
1
2021
587
0.130
Why?
Consensus
1
2019
465
0.120
Why?
Intercellular Signaling Peptides and Proteins
2
2015
372
0.120
Why?
Esophageal Neoplasms
1
2021
351
0.120
Why?
Programmed Cell Death 1 Receptor
1
2019
268
0.120
Why?
Digestive System Neoplasms
1
2016
9
0.120
Why?
Antineoplastic Agents, Immunological
1
2019
200
0.120
Why?
Neoplasm Recurrence, Local
2
2023
1156
0.120
Why?
Liver Neoplasms
2
2024
774
0.120
Why?
Adolescent
5
2026
22451
0.120
Why?
Insulin-Like Growth Factor I
1
2018
318
0.120
Why?
Time Factors
2
2019
7079
0.120
Why?
Hospitals
1
2021
730
0.120
Why?
Edema
1
2016
129
0.120
Why?
Triple Negative Breast Neoplasms
1
2019
219
0.120
Why?
Biomarkers
3
2023
4329
0.120
Why?
GPI-Linked Proteins
1
2016
81
0.110
Why?
Diabetic Neuropathies
1
2016
100
0.110
Why?
Biliary Tract Neoplasms
1
2015
30
0.110
Why?
Device Approval
1
2015
19
0.110
Why?
Immunoblotting
1
2015
294
0.110
Why?
Receptor, Notch1
1
2015
62
0.110
Why?
Mice
7
2025
18266
0.110
Why?
Neuralgia
1
2016
140
0.110
Why?
Patient Care Planning
1
2016
170
0.110
Why?
Gene Dosage
1
2015
146
0.110
Why?
Pancreas
1
2017
342
0.110
Why?
Health Behavior
1
2020
801
0.110
Why?
Analgesics
1
2016
231
0.110
Why?
Delivery of Health Care, Integrated
1
2018
304
0.110
Why?
Gene Expression Regulation
1
2024
2591
0.110
Why?
Drug Approval
1
2015
93
0.100
Why?
Administration, Oral
1
2017
867
0.100
Why?
DNA Copy Number Variations
1
2015
189
0.100
Why?
Quality of Life
2
2024
3187
0.100
Why?
Quinazolines
1
2015
267
0.100
Why?
Immunoconjugates
1
2016
138
0.100
Why?
Genetic Variation
1
2019
992
0.100
Why?
United States Food and Drug Administration
1
2015
207
0.100
Why?
Phenotype
2
2021
3186
0.100
Why?
Delivery of Health Care
1
2021
942
0.100
Why?
Proto-Oncogene Proteins
1
2017
615
0.100
Why?
Oligonucleotide Array Sequence Analysis
1
2015
751
0.100
Why?
Liquid Biopsy
2
2025
16
0.100
Why?
beta Catenin
1
2015
250
0.100
Why?
Lung Neoplasms
2
2024
2674
0.100
Why?
Lymphocytes
1
2015
379
0.090
Why?
Spinal Cord Injuries
1
2016
238
0.090
Why?
National Cancer Institute (U.S.)
2
2025
55
0.090
Why?
Randomized Controlled Trials as Topic
1
2019
1754
0.090
Why?
Registries
1
2021
2382
0.090
Why?
Risk
1
2014
917
0.090
Why?
Protein Kinase Inhibitors
1
2018
982
0.090
Why?
Angiogenesis Inhibitors
1
2013
238
0.090
Why?
Ligands
1
2013
676
0.080
Why?
Neoplasm, Residual
2
2022
143
0.080
Why?
Prospective Studies
3
2022
8087
0.080
Why?
Protein-Tyrosine Kinases
1
2013
429
0.080
Why?
Patient Care Team
1
2016
700
0.080
Why?
Activities of Daily Living
1
2014
438
0.080
Why?
Apoptosis
3
2022
2436
0.080
Why?
Mice, Nude
2
2024
665
0.080
Why?
Streptococcaceae
1
2009
2
0.070
Why?
Cytokines
2
2015
2079
0.070
Why?
Clinical Medicine
1
2009
26
0.070
Why?
Neutrophils
1
2015
1132
0.070
Why?
Patient Satisfaction
1
2013
698
0.070
Why?
Transcriptome
1
2015
1066
0.070
Why?
Chemoradiotherapy
2
2023
238
0.070
Why?
Myositis
1
2009
57
0.070
Why?
Sulindac
1
2008
16
0.070
Why?
Bortezomib
1
2008
54
0.070
Why?
Mutation Rate
2
2019
37
0.070
Why?
Taiwan
1
2008
48
0.070
Why?
Combined Modality Therapy
1
2011
1269
0.070
Why?
Nausea
1
2008
111
0.070
Why?
Immunoenzyme Techniques
1
2008
196
0.070
Why?
Multivariate Analysis
3
2017
1531
0.070
Why?
Neutropenia
1
2008
153
0.060
Why?
Fluphenazine
1
2007
3
0.060
Why?
Risperidone
1
2007
27
0.060
Why?
Nerve Fibers, Myelinated
1
2007
47
0.060
Why?
Drug Therapy, Combination
1
2010
1034
0.060
Why?
Food
1
2008
149
0.060
Why?
Exons
1
2008
361
0.060
Why?
Anemia
1
2008
189
0.060
Why?
Fasting
1
2008
280
0.060
Why?
Thrombocytopenia
1
2008
205
0.060
Why?
Frontal Lobe
1
2007
159
0.060
Why?
Administrative Personnel
1
2025
33
0.060
Why?
Gastrectomy
2
2017
162
0.060
Why?
Antipsychotic Agents
1
2007
178
0.060
Why?
Propensity Score
2
2017
370
0.050
Why?
Polymerase Chain Reaction
1
2008
1030
0.050
Why?
Stroke
1
2014
1283
0.050
Why?
Postoperative Complications
1
2017
2962
0.050
Why?
Follow-Up Studies
2
2026
5397
0.050
Why?
Survival Analysis
2
2017
1372
0.050
Why?
Loneliness
1
2024
69
0.050
Why?
Fluorescent Dyes
1
2025
340
0.050
Why?
Health Care Surveys
1
2025
538
0.050
Why?
Delayed Diagnosis
1
2024
102
0.050
Why?
Natural Language Processing
1
2024
103
0.050
Why?
Oxidative Stress
1
2010
1367
0.050
Why?
Thymine
1
2022
16
0.050
Why?
Cyclooxygenase 2 Inhibitors
1
2022
24
0.050
Why?
Paclitaxel
1
2024
258
0.050
Why?
G2 Phase Cell Cycle Checkpoints
1
2022
43
0.050
Why?
Mice, Inbred BALB C
1
2025
1244
0.050
Why?
Equivalence Trials as Topic
1
2022
34
0.050
Why?
Recombinant Fusion Proteins
1
2025
662
0.050
Why?
Endothelial Growth Factors
1
2022
61
0.050
Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
69
0.050
Why?
Gallium Radioisotopes
1
2022
16
0.050
Why?
Resilience, Psychological
1
2024
140
0.050
Why?
Receptors, Peptide
1
2022
18
0.050
Why?
Radioisotopes
1
2022
37
0.040
Why?
Intestinal Neoplasms
1
2022
31
0.040
Why?
Radionuclide Imaging
1
2022
116
0.040
Why?
Inflammasomes
1
2023
145
0.040
Why?
Organoids
1
2024
143
0.040
Why?
Pyrrolidines
1
2022
126
0.040
Why?
Neoplastic Syndromes, Hereditary
1
2021
47
0.040
Why?
North America
1
2022
299
0.040
Why?
Quinolines
1
2022
191
0.040
Why?
Radiopharmaceuticals
1
2022
210
0.040
Why?
Europe
1
2022
420
0.040
Why?
Positron Emission Tomography Computed Tomography
1
2022
122
0.040
Why?
Chimerism
1
2021
35
0.040
Why?
Immune Tolerance
1
2023
384
0.040
Why?
Preventive Medicine
1
2021
38
0.040
Why?
Lymphocyte Subsets
1
2021
79
0.040
Why?
Surveys and Questionnaires
2
2024
6050
0.040
Why?
Canada
1
2022
430
0.040
Why?
Lymphoid Tissue
1
2021
82
0.040
Why?
Hyaluronic Acid
1
2022
226
0.040
Why?
Positron-Emission Tomography
1
2022
342
0.040
Why?
Mice, SCID
1
2021
360
0.040
Why?
Geography
1
2020
186
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2022
226
0.040
Why?
Morbidity
1
2021
317
0.040
Why?
SEER Program
1
2020
233
0.040
Why?
Mice, Inbred C57BL
2
2023
6021
0.040
Why?
Mice, Inbred NOD
1
2021
598
0.040
Why?
Spectrophotometry, Infrared
1
2019
52
0.040
Why?
District of Columbia
1
2018
37
0.030
Why?
Karnofsky Performance Status
1
2018
37
0.030
Why?
Sulfonamides
1
2022
592
0.030
Why?
Pyridines
1
2022
606
0.030
Why?
Structure-Activity Relationship
1
2019
561
0.030
Why?
Melanoma
1
2024
764
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
155
0.030
Why?
Colon
1
2020
304
0.030
Why?
Fluorescein Angiography
1
2019
195
0.030
Why?
Multimodal Imaging
1
2019
138
0.030
Why?
Half-Life
1
2017
157
0.030
Why?
RNA
1
2024
925
0.030
Why?
American Medical Association
1
2017
19
0.030
Why?
Genome, Human
1
2019
425
0.030
Why?
Gene Expression Profiling
1
2024
1790
0.030
Why?
Reproducibility of Results
1
2024
3396
0.030
Why?
Tomography, Optical Coherence
1
2019
277
0.030
Why?
Needles
1
2016
61
0.030
Why?
Cell Proliferation
1
2024
2497
0.030
Why?
Radiotherapy, Adjuvant
1
2017
222
0.030
Why?
Delphi Technique
1
2018
347
0.030
Why?
Infusions, Intravenous
1
2017
429
0.030
Why?
Genomic Instability
1
2017
64
0.030
Why?
Radiotherapy, Intensity-Modulated
1
2017
143
0.030
Why?
Molecular Diagnostic Techniques
1
2017
104
0.030
Why?
Meta-Analysis as Topic
1
2017
173
0.030
Why?
Health Services Needs and Demand
1
2018
283
0.030
Why?
Retreatment
1
2016
79
0.030
Why?
Algorithms
1
2024
1843
0.030
Why?
DNA Mutational Analysis
1
2017
409
0.030
Why?
Incidental Findings
1
2016
81
0.030
Why?
Platinum
1
2016
48
0.030
Why?
Acute Disease
1
2019
1033
0.030
Why?
Serrate-Jagged Proteins
1
2015
27
0.030
Why?
Jagged-1 Protein
1
2015
22
0.030
Why?
Gene Frequency
1
2017
495
0.030
Why?
Neoplasm Invasiveness
1
2017
503
0.030
Why?
Radiography
2
2016
856
0.030
Why?
Gene Duplication
1
2015
67
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2021
700
0.030
Why?
Endoscopy, Digestive System
1
2016
141
0.030
Why?
Protein Isoforms
1
2016
388
0.030
Why?
Practice Guidelines as Topic
1
2022
1581
0.030
Why?
Preoperative Care
1
2017
375
0.030
Why?
Analysis of Variance
1
2017
1293
0.030
Why?
Leukocyte Count
1
2015
319
0.030
Why?
Magnetic Resonance Imaging
1
2007
3917
0.030
Why?
Calcium-Binding Proteins
1
2015
219
0.030
Why?
Ultraviolet Rays
1
2016
376
0.030
Why?
Mice, Knockout
1
2021
3121
0.020
Why?
Societies, Medical
1
2018
901
0.020
Why?
Behavior, Animal
1
2016
530
0.020
Why?
Protein Processing, Post-Translational
1
2016
485
0.020
Why?
CD8-Positive T-Lymphocytes
1
2019
929
0.020
Why?
Brain Neoplasms
1
2021
1324
0.020
Why?
Logistic Models
1
2017
2112
0.020
Why?
Skin
1
2016
701
0.020
Why?
Immunohistochemistry
1
2016
1709
0.020
Why?
Rats, Sprague-Dawley
1
2016
2533
0.020
Why?
Cross-Sectional Studies
1
2022
5875
0.020
Why?
Lung
1
2023
4119
0.020
Why?
Protein Binding
1
2016
2239
0.020
Why?
Angiogenesis Inducing Agents
1
2009
24
0.020
Why?
Glycogen Synthase Kinase 3 beta
1
2008
74
0.020
Why?
Rats
1
2016
5574
0.020
Why?
Glycogen Synthase Kinase 3
1
2008
83
0.020
Why?
Reference Standards
1
2008
176
0.020
Why?
Pharmacogenetics
1
2008
176
0.020
Why?
Infusions, Intra-Arterial
1
1986
61
0.010
Why?
Hepatic Artery
1
1986
52
0.010
Why?
Chromatography, High Pressure Liquid
1
2008
588
0.010
Why?
Breast Neoplasms
1
2019
2411
0.010
Why?
Predictive Value of Tests
1
2011
2097
0.010
Why?
Reference Values
1
2007
787
0.010
Why?
Tomography, X-Ray Computed
1
2016
2766
0.010
Why?
Tandem Mass Spectrometry
1
2008
574
0.010
Why?
Image Processing, Computer-Assisted
1
2007
774
0.010
Why?
Longitudinal Studies
1
2007
3005
0.010
Why?
Lieu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)